---
figid: PMC7056524__nihms-1544769-f0001
figlink: pmc/articles/PMC7056524/figure/F1/
number: F1
caption: 'In normal B cells, Mir-15/16 target Bcl2. BAC and BAD can activate apoptosis.
  ROR1 is not expressed thus Wnt5a cannot activate the proliferation pathway (A).
  In leukemic cells, lack of miR-15/16 is the cause of Bcl2 overexpression that leads
  to apoptosis inhibition. ROR1 is expressed in the surface of leukemic cells thus
  wnt5a activates the proliferation pathway (B). Therapeutic implication of combined
  treatment with Venetoclax, that targets Bcl2 and Cirmtuzumab that binds to ROR1:
  the antiapoptotic pathway is initiated and the cell proliferation pathway is inhibited
  (C).'
pmcid: PMC7056524
papertitle: MicroRNA dysregulation and multi-targeted therapy for cancer treatment.
reftext: Veronica Balatti, et al. Adv Biol Regul. ;75:100669-100669.
pmc_ranked_result_index: '41709'
pathway_score: 0.6071543
filename: nihms-1544769-f0001.jpg
figtitle: In normal B cells, Mir-15/16 target Bcl2
year: ''
organisms:
- Mus musculus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7056524__nihms-1544769-f0001.html
  '@type': Dataset
  description: 'In normal B cells, Mir-15/16 target Bcl2. BAC and BAD can activate
    apoptosis. ROR1 is not expressed thus Wnt5a cannot activate the proliferation
    pathway (A). In leukemic cells, lack of miR-15/16 is the cause of Bcl2 overexpression
    that leads to apoptosis inhibition. ROR1 is expressed in the surface of leukemic
    cells thus wnt5a activates the proliferation pathway (B). Therapeutic implication
    of combined treatment with Venetoclax, that targets Bcl2 and Cirmtuzumab that
    binds to ROR1: the antiapoptotic pathway is initiated and the cell proliferation
    pathway is inhibited (C).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BAX
  - GDE1
  - BAD
  - BCL2
  - WNT5A
genes:
- word: Вах
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: miR-16
  symbol: MIR16
  source: hgnc_alias_symbol
  hgnc_symbol: GDE1
  entrez: '51573'
- word: Вad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: miR-16
  symbol: MIR16
  source: hgnc_alias_symbol
  hgnc_symbol: GDE1
  entrez: '51573'
- word: Вах
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: (Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: (Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt5a)
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: (Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
chemicals: []
diseases: []
figid_alias: PMC7056524__F1
redirect_from: /figures/PMC7056524__F1
figtype: Figure
---
